New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Disability bias complaints peak as the office that investigates them is gutted September 19, 2025 A weekly injection could replace painful daily treatment for rare fat disorder January 30, 2025 Breakthrough in mirror molecule synthesis opens doors for drug discovery October 10, 2024